<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Nutrition support in intubated critically ill adult patients: Initial evaluation and prescription</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Nutrition support in intubated critically ill adult patients: Initial evaluation and prescription</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Nutrition support in intubated critically ill adult patients: Initial evaluation and prescription</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">David Seres, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Polly E Parsons, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Geraldine Finlay, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 29, 2024.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Nutrition support refers to the enteral or parenteral provision of calories, protein, electrolytes, vitamins, minerals, trace elements, and fluids. Acute critical illness is characterized by catabolism exceeding anabolism [<a href="#rid1">1-3</a>]. In contrast, the phase of recovery is characterized by anabolism exceeding catabolism. Understanding the importance of nutrition is critical when managing all phases of critical illness.</p><p>Indications, contraindications, and appropriate prescription of nutrition in critically ill patients are discussed in this topic. Our usual approach is, for the most part, supported by several international guidelines, although differences may exist as new data emerge [<a href="#rid4">4-7</a>].</p><p>Aspects that are specific to enteral and <a class="drug drug_general" data-topicid="10307" href="/z/d/drug information/10307.html" rel="external">parenteral nutrition</a> are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/1605.html" rel="external">"Nutrition support in intubated critically ill adult patients: Enteral nutrition"</a> and  <a class="medical medical_review" href="/z/d/html/1626.html" rel="external">"Nutrition support in intubated critically ill adult patients: Parenteral nutrition"</a>.)</p><p class="headingAnchor" id="H1207451404"><span class="h1">INITIAL EVALUATION</span><span class="headingEndMark"> — </span>Once a patient is admitted to the intensive care unit (ICU), we assess the patient's nutritional status, need for nutritional support, and the presence of any contraindications to select modes of delivery. In general, oral feeding is preferred over enteral support, and enteral feeding preferred over parenteral support. However, individual morbidities may impact this choice. In the ICU, where many patients are intubated or on noninvasive modes of ventilation, oral feeding is not typically a reasonable option. Thus, by default, enteral feeding is our usual mode of nutritional support unless contraindications exist (eg, small bowel obstruction). (See <a class="local">'Adequately nourished patients'</a> below.)</p><p class="headingAnchor" id="H2812436807"><span class="h2">Assess nutritional status</span><span class="headingEndMark"> — </span>Our approach to assessing nutritional status is the following:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Dry body weight and body mass index (BMI)</strong> – We perform an initial evaluation of nutritional status that involves measuring the current dry body weight and calculating the BMI (<a class="calc calc_patient" href="/z/d/html/13480.html" rel="external">calculator 1</a>). Patients can be categorized as the following:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Normal weight – BMI between 18.5 to 24.9 kg/m<sup>2</sup></p><p class="bulletIndent2"><span class="glyph">•</span>Overweight – BMI 25 to 29.9 kg/m<sup>2</sup></p><p class="bulletIndent2"><span class="glyph">•</span>Underweight – BMI &lt;18.5 kg/m<sup>2</sup></p><p class="bulletIndent2"><span class="glyph">•</span>Obese – BMI ≥30 kg/m<sup>2</sup></p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Signs of malnutrition</strong> – We also examine patients for signs of malnutrition. Criteria for diagnosing malnutrition have been published [<a href="#rid8">8-11</a>] and have been validated to predict length of stay, ICU readmission, and mortality in critically ill patients [<a href="#rid10">10,12</a>]. The syndrome of malnutrition includes both of the following:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Wasting due to starvation (also known as malnourishment) – Patients with wasting due to starvation are malnourished and responsive to nourishment.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Wasting due to catabolism – Wasting due to catabolism is common in critically ill adults (inflammation-related muscle wasting, insulin resistance, hypoproteinemias, immune suppression) [<a href="#rid8">8,9</a>]. Patients with wasting due to catabolism are <strong>not</strong> malnourished and are <strong>not</strong> responsive to nourishment [<a href="#rid13">13-15</a>]. However, patients with catabolism are also more likely to also have starvation and may also be malnourished.</p><p></p><p class="bulletIndent1">Evidence that a patient has malnutrition includes poor nutritional intake accompanied by unintentional weight loss or low body weight. Examples include the following [<a href="#rid16">16</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A BMI less than 18.5 kg/m<sup>2</sup></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Unintentional loss of more than 2.3 kg (5 lbs) or 5 percent of body weight over one month</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Unintentional loss of more than 4.5 kg (10 lbs) or 10 percent of body weight over six months</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Others include muscle wasting (eg, temporal muscle wasting, sunken supraclavicular fossae, scaphoid abdomen), decreased adipose stores, and signs of vitamin deficiencies  (<a class="graphic graphic_table graphicRef78426" href="/z/d/graphic/78426.html" rel="external">table 1</a>)</p><p></p><p class="bulletIndent1">The precise duration necessary for malnourishment to develop is unknown and probably varies among patients. As a general guideline, it is reasonable to assume that starvation-related malnutrition is impending in any patient who has had little or no nutritional intake for two weeks. For patients with antecedent undernourishment, one week or less may be more accurate. Inflammation-related malnutrition may develop indolently but may also develop in hours to days with severe illness. Thus, reassessment of nutritional status is important during critical illness.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Laboratory assessment</strong> – Although nutritional chemistries are often measured and are prognostic indicators of poor outcome, we and other experts are not proponents of this approach [<a href="#rid17">17,18</a>]. Such surrogates, particularly reduced serum proteins (eg, albumin, prealbumin/transthyretin), are nonspecific and should be assumed to be due to systemic inflammatory critical illness. In addition, they are not responsive to nutrient intake and therefore, cannot be used as therapeutic biomarkers.</p><p></p><p class="headingAnchor" id="H3166731027"><span class="h2">Assess indications and contraindications</span></p><p class="headingAnchor" id="H162293115"><span class="h3">Indications</span><span class="headingEndMark"> — </span>Once a patient is admitted into the ICU, we assess the need for nutritional support.</p><p class="bulletIndent1"><span class="glyph">●</span>Extubation expected within 36 hours – Adequately nourished patients who are expected to be extubated within 24 to 36 hours of admission and are likely able to eat after extubation typically do not need enteral or parenteral support since oral nutrition is considered optimal.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Mechanical ventilation expected beyond 36 hours – This population needs nutritional support, typically enteral support, unless contraindications exist, in which case we consider parenteral support (see <a class="local">'Contraindications'</a> below). In situations where contraindications to enteral nutrition (EN) are expected to resolve quickly, such as minor vomiting or gastrointestinal bleeding, <a class="drug drug_general" data-topicid="10307" href="/z/d/drug information/10307.html" rel="external">parenteral nutrition</a> (PN) may be administered until enteral feeding is deemed safe or the patient is extubated and can eat safely.</p><p></p><p class="headingAnchor" id="H1044488847"><span class="h3">Contraindications</span><span class="headingEndMark"> — </span>Contraindications to enteral and parenteral feeding are listed in the table  (<a class="graphic graphic_table graphicRef143318" href="/z/d/graphic/143318.html" rel="external">table 2</a>).</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Enteral nutrition (EN)</strong> — General contraindications to enteral feeding include the following:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Hemodynamic instability/shock – We generally do not administer EN to critically ill patients who are both hemodynamically unstable and have not had their intravascular volume fully resuscitated since such patients may be predisposed to bowel ischemia [<a href="#rid6">6,19,20</a>]. Thus, many patients with critical illness are not candidates for EN immediately after ICU admission. As an example, one randomized trial reported that in critically ill adults with shock, early EN did not reduce mortality or infections and was associated with a greater risk of digestive complications compared with early PN [<a href="#rid20">20</a>].</p><p></p><p class="bulletIndent2">If there is evidence for adequate volume resuscitation and tissue perfusion, hemodynamic instability by itself, unless severe, is not a contraindication for EN [<a href="#rid21">21</a>]. Similarly, enteral feeding does not necessarily need to be stopped for transient, mild periods of hemodynamic instability, which can commonly punctuate a patient's course during critical illness. Recurrent unnecessary holding of tube feeding can result in large calorie deficits and should be avoided when possible.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Others – Other contraindications to EN include the following:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Bowel obstruction</p><p class="bulletIndent3"><span class="glyph">-</span>Severe and protracted ileus</p><p class="bulletIndent3"><span class="glyph">-</span>Major upper gastrointestinal bleeding</p><p class="bulletIndent3"><span class="glyph">-</span>Intractable vomiting</p><p class="bulletIndent3"><span class="glyph">-</span>Gastrointestinal ischemia</p><p class="bulletIndent3"><span class="glyph">-</span>High-output gastrointestinal fistula</p><p class="bulletIndent3"><span class="glyph">-</span>Abdominal compartment syndrome</p><p></p><p class="bulletIndent1">Some conditions previously considered contraindications to EN are no longer considered as such. Examples include hyperemesis gravidarum and the absence of bowel sounds or flatus following routine colorectal surgery or surgery for bowel perforation [<a href="#rid22">22-27</a>]. While such patients remain at increased risk for vomiting, enteral feeding does not appear to impart an increased risk for infection or pneumonia.</p><p></p><p class="bulletIndent1">In addition, a new gastrointestinal anastomosis distal to the infusion site that the surgeon feels is at risk of dehiscence was once considered a contraindication until data indicated that early feeding strengthens anastomoses [<a href="#rid28">28</a>]. Whether this applies to all anastomoses is unknown, and when the anastomoses are felt to be tenuous (eg, gastric bypass surgery), we defer to the surgeon's judgement as to whether EN should be started.</p><p></p><p class="bulletIndent1">High gastric residual volume (GRV) is not an absolute contraindication to enteral feeding, although holding feeding when residual volumes are &gt;500 mL is acceptable. Management of high GRV is discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/1605.html" rel="external">"Nutrition support in intubated critically ill adult patients: Enteral nutrition", section on 'Measure gastric residual volume'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="10307" href="/z/d/drug information/10307.html" rel="external">Parenteral nutrition</a><strong> (PN)</strong> — Contraindications to PN include the following:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Severe hyperglycemia</p><p class="bulletIndent2"><span class="glyph">•</span>Severe electrolyte abnormalities</p><p class="bulletIndent2"><span class="glyph">•</span>Volume overload</p><p class="bulletIndent2"><span class="glyph">•</span>Inadequate intravenous access</p><p class="bulletIndent2"><span class="glyph">•</span>Inadequate attempts to feed enterally</p><p></p><p class="headingAnchor" id="H2389676115"><span class="h1">ADEQUATELY NOURISHED PATIENTS</span><span class="headingEndMark"> — </span>Most patients who are admitted to the intensive care unit (ICU) are adequately nourished. This section discusses timing and optimal type of nutrition support for patients who are adequately nourished or have not developed disease-related malnutrition prior to becoming critically ill. Historically, most of the evidence related to nutrition support is derived from patients who are adequately nourished since clinical trials have typically excluded patients with malnutrition. Generally, enteral, rather than parenteral, feeding and early (eg, 36 to 48 hours), rather than delayed, support is preferred.</p><p class="headingAnchor" id="H707372776"><span class="h2">Timing and type of nutrition</span></p><p class="headingAnchor" id="H1221486328"><span class="h3">Patients without contraindications to enteral nutrition</span><span class="headingEndMark"> — </span>For adequately nourished critically ill patients without contraindications to enteral nutrition (EN), we suggest early rather than delayed EN. (See <a class="local">'Early enteral nutrition'</a> below.)</p><p class="headingAnchor" id="H1123343279"><span class="h4">Early enteral nutrition</span><span class="headingEndMark"> — </span>Support for early EN is derived from evidence in critically ill patients that supports a possible mortality benefit and reduction in infections when early EN (eg, 48 to 36 hours) is compared with delayed EN. However, the evidence for this approach is limited, often conflicting, and lower quality for patients with medical conditions compared with surgical conditions (eg, trauma, peritonitis, pancreatitis, burns).</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Early versus delayed EN</strong> – Evidence on the impact of early EN on the rate of infectious complications and mortality suggest a possible benefit when compared with delayed EN [<a href="#rid4">4,20,29-31</a>]. As an example, a 2018 meta-analysis of 16 trials totaling 3225 medical and surgical critically ill patients compared early EN with delayed EN [<a href="#rid30">30</a>]. Early EN resulted in a significant reduction in pneumonia when compared with delayed EN (odds ratio [OR] 0.75, 95% CI 0.60-0.94). However, there were few events (21 episodes of pneumonia), limiting the certainty of this finding. Data from six trials (236 patients) reported a reduction in mortality when early EN was compared with delayed EN (OR 0.45, 95% CI 0.21-0.95) [<a href="#rid30">30</a>]. However, there were also few events (33 total deaths), limiting the certainty of this finding. An earlier meta-analysis of 11 trials reached a similar conclusion [<a href="#rid4">4</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Early EN versus early PN</strong> – In the same 2018 meta-analysis, while infectious rates were lower when early EN was compared with early <a class="drug drug_general" data-topicid="10307" href="/z/d/drug information/10307.html" rel="external">parenteral nutrition</a> (PN), the finding was not statistically significant (OR 0.80, 95% CI 0.63-1) [<a href="#rid30">30</a>]. Similarly, no mortality difference was found when early EN was compared with early PN (OR 1.04, 95% CI 0.89-1.22).</p><p></p><p class="bulletIndent1">In addition, two large randomized trials (only one of which was included in the meta-analysis) reported similar outcomes when early enteral and early parenteral feeding strategies were compared in critically ill adults [<a href="#rid20">20,29</a>]. These trials are discussed in detail below. (See <a class="local">'Early parenteral nutrition'</a> below.)</p><p></p><p>Very early and aggressive feeding does not appear to be of benefit and may be harmful. One randomized trial of 78 critically ill patients was stopped early due to greater mortality in patients receiving very early (within six hours of hemodynamic stability) and aggressive (&gt;75 percent of goal) EN compared with patients who received standard nutritional support [<a href="#rid31">31</a>]. Another randomized trial of 3044 ventilated patients with shock also reported no mortality benefit associated with early feeding within 24 hours of intubation [<a href="#rid32">32</a>].</p><p>For patients who do not meet their caloric and protein goals during the first week of critical illness, we do not administer supplemental PN in order to reach those caloric goals since it does not alter outcomes [<a href="#rid6">6</a>]. While small individual studies reported a possible benefit [<a href="#rid33">33,34</a>], a meta-analysis of five studies reported similar outcomes when EN plus supplemental PN was compared with early EN without supplementation [<a href="#rid6">6</a>].</p><p>The calculation of caloric needs is described separately. (See <a class="local">'Calorie prescription'</a> below.)</p><p class="headingAnchor" id="H4271869650"><span class="h3">Patients with contraindications to enteral feeding</span><span class="headingEndMark"> — </span>For adequately nourished patients with contraindications to EN  (<a class="graphic graphic_table graphicRef143318" href="/z/d/graphic/143318.html" rel="external">table 2</a>), we suggest early PN (eg, 36 to 48 hours) rather than delaying nutrition. This approach is based on indirect data suggesting that when PN is administered in the short-term (ie, the first week of critical illness) with a view to transitioning to EN later, outcomes are the same as patients receiving early EN [<a href="#rid6">6,20,29</a>]. It is unknown if this recommendation applies to patients who cannot transition to EN and have a potential need for PN beyond the first week of critical illness. These data are discussed below. (See <a class="local">'Early parenteral nutrition'</a> below.)</p><p class="headingAnchor" id="H2522341895"><span class="h4">Early parenteral nutrition</span><span class="headingEndMark"> — </span>While delayed PN was preferred in the past, data now suggest that the provision of early PN (up to 36 hours from the start of critical illness or surgery) does not alter mortality when compared with early EN or late PN, although there may be a positive impact of early PN on infectious risk when compared with early EN [<a href="#rid4">4,6,20,29</a>].</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Early EN versus late PN</strong> – There are limited data suggesting that early PN is not associated with harm, may be no different when compared with late PN, and may improve the number of ventilator-free days or length of stay in the ICU or hospital [<a href="#rid33">33,35,36</a>]. However, a mortality benefit has not been shown and data are inconsistent.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Early PN versus early EN</strong> – Indirect evidence suggests early PN has similar outcomes when compared with EN:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>One 2017 meta-analysis of seven randomized trials that compared early EN with early PN reported similar mortality rates (risk ratio [RR] 0.95, 95% CI 0.76-1.19; moderate certainty) but a reduced risk of infections with early PN (RR 0.55, 95% CI 0.35-0.86; low certainty) [<a href="#rid4">4</a>]. However, patients were unselected and mostly surgical, the risk of bias was high, and there was significant heterogeneity among the included trials.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Two large randomized trials (one of which was included in the above meta-analysis) compared early EN with early PN, starting within 36 hours of admission or 24 hours after intubation [<a href="#rid20">20,29</a>]. In one study, patients on PN were allowed to transition to EN after three days if the underlying critical illness was resolving [<a href="#rid20">20</a>], and in the other study, the intervention continued for five days only [<a href="#rid29">29</a>]. Both studies found similar 30- or 90-day mortality but, as expected, also found an increased incidence of gastrointestinal side effects in the enteral feeding group (eg, vomiting). Adverse events, including infection rates, were similar. However, the studies were not blinded and one was stopped early for futility.</p><p></p><p>Supplemental PN in patients receiving early EN (to improve provision of calories and protein) does not appear beneficial and is discussed separately. (See <a class="local">'Early enteral nutrition'</a> above.)</p><p class="headingAnchor" id="H12"><span class="h2">Calculating calorie and protein requirements in adequately nourished patients</span><span class="headingEndMark"> — </span>Once it has been determined that a critically ill patient will receive nutrition support, the patient's nutritional requirements must be determined. For most adequately nourished patients who have a normal body weight (body mass index [BMI] 18.5 to 24.9 kg/m<sup>2</sup>) or who are overweight (BMI 25 to 29.9 kg/m<sup>2</sup>), we use the current weight as the dosing weight (see <a class="local">'Dosing weight'</a> below). We target 25 to 30 kilocalories (kcal)/kg (see <a class="local">'Calorie prescription'</a> below); 1.2 to 2.0 g/kg of protein per day (ie, high-protein diet) (see <a class="local">'Protein prescription'</a> below); and the recommended daily allowance of electrolytes, vitamins, minerals, and trace elements (see <a class="local">'Electrolytes, vitamins, minerals, trace elements'</a> below). We initiate feeding at 12 kcal/kg of dosing weight per day and slowly increase to the target over the ensuing three to seven days, shorter if on PN (eg, two to three days).</p><p>These requirements are used to select the appropriate formulation and rate of administration. Formulations for EN and PN are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/1605.html" rel="external">"Nutrition support in intubated critically ill adult patients: Enteral nutrition"</a> and  <a class="medical medical_review" href="/z/d/html/1626.html" rel="external">"Nutrition support in intubated critically ill adult patients: Parenteral nutrition"</a>.)</p><p class="headingAnchor" id="H13"><span class="h3">Dosing weight</span><span class="headingEndMark"> — </span>For adequately nourished patients who have a normal body weight (BMI 18.5 to 24.9 kg/m<sup>2</sup>) or who are overweight (BMI 25 to 29.9 kg/m<sup>2</sup>), we use the current weight as the dosing weight. Definition and dosing weight for patients who are underweight (&lt;18.5 kg/m<sup>2</sup>) or have obesity (BMI ≥30 kg/m<sup>2</sup>) are discussed below. (See <a class="local">'Assess nutritional status'</a> above and <a class="local">'Patients with malnutrition'</a> below and <a class="local">'Patients with obesity'</a> below.)</p><p>Calories and protein needs are calculated based upon the dry body weight of the individual patient (ie, the "dosing weight"). Estimating the dry body weight is not an exact science and can be challenging in the critically ill patient due to hyper- or hypovolemia. For example, we sometimes compare current with admission or previous body weight to facilitate estimation of dry body weight.</p><p>While some experts calculate calorie prescription based upon measured resting energy expenditure (eg, using indirect calorimetry), this is impractical for most settings due to cost of equipment and maintenance of expertise.</p><p class="headingAnchor" id="H14"><span class="h3">Calorie prescription</span><span class="headingEndMark"> — </span>For adequately nourished critically ill patients, we initially provide 12 kcal/kg of dosing weight per day (see <a class="local">'Dosing weight'</a> above) and slowly increase to 25 to 30 kcal/kg in the next seven days, shorter for those on PN (eg, two to three days). While guidelines suggest a starting range between 12 and 25 kcal/kg of dosing weight per day [<a href="#rid6">6</a>], there is clinical equipoise regarding the optimal approach. We prefer to start at the lower end of this range to avoid potential harm from overfeeding and intolerance.</p><p>Hypocaloric feeding (eg, 8 to 10 kcal/kg dosing weight) during the first week of critical illness has been controversial [<a href="#rid37">37-39</a>]. Early trials suggested benefit (eg, less gastrointestinal intolerance, fewer infections) compared with normocaloric feeding [<a href="#rid40">40-42</a>], resulting in a paradigm shift in practice towards hypocaloric feeding in the 2000s. Since then, meta-analyses and guideline groups have reported similar outcomes when hypocaloric or normocaloric strategies are used during the first week of critical illness [<a href="#rid6">6,40,42-44</a>]. However, the effect is uncertain due in part to the broad range of imprecision in studies suggesting that outcomes may be beneficial or harmful when hypocaloric or aggressive feeding is used. It should also be noted that existing studies often focus on the first week of critical illness, but the impact of such a calorie prescription in those with prolonged critical illness is unknown.</p><p>Best supporting a normocaloric strategy is a 2022 meta-analysis of 14 trials that compared higher with lower energy intake. The analysis reported similar 28-day mortality (risk difference [RD] 0, 95% CI -0.02 to 0.02); ICU mortality (RD 0, 95% CI -0.03 to 0.03); and other outcomes including length of stay, infectious complications (eg, bacteremia or pneumonia, any infection), and ventilator days [<a href="#rid6">6</a>]. However, there was very low confidence in the results due to a significant degree of clinical heterogeneity, high risk of bias, inconsistency, and imprecision. An earlier meta-analysis showed similar findings [<a href="#rid43">43</a>].</p><p class="headingAnchor" id="H15"><span class="h3">Protein prescription</span><span class="headingEndMark"> — </span>In critically ill patients, we prescribe 1.2 to 2.0 g/kg of protein per day (ie, high-protein diet). For most patients, amounts on the lower end of this range may be sufficient while patients with severe burns, trauma, or obesity may benefit from rates on the higher end. We do not reduce the amount of protein in patients with kidney disease since clinical trials have shown that critically ill patients with kidney failure can tolerate protein intake as high as 2.5 g/kg per day [<a href="#rid45">45</a>]. We perform an ongoing assessment of the patient's clinical condition as it impacts protein prescription estimates over the course of their illness.</p><p>This approach is based upon limited data in unselected critically ill patients and indirect data derived from patients with burns or obesity that support improved surrogate outcomes, such as hand grip strength or muscle mass with a high protein strategy [<a href="#rid46">46-50</a>]. This approach is also supported by the practical observation that most patients actually receive an amount significantly less than that prescribed due to frequent feeding difficulties encountered in this population [<a href="#rid46">46</a>] and that protein requirements increase as the illness becomes more severe [<a href="#rid51">51</a>]. Thus, it is thought that this strategy mitigates further muscle protein loss incurred by severe critical illness itself.</p><p>Data suggest no meaningful mortality benefit when high-dose versus low-dose prescriptions for protein in critically ill patients are compared, although data are flawed:</p><p class="bulletIndent1"><span class="glyph">●</span>A multicenter, single-blinded randomized trial of 1301 mechanically ventilated patients (most of whom had a medical condition, most often respiratory failure) who were considered at high nutritional risk compared treatment with a high protein prescription (≥2·2 g/kg per day) with the usual dose protein prescription (≤1.2 g/kg per day) [<a href="#rid52">52</a>]. High nutritional risk was defined as low BMI (≤25 kg/m²), high BMI (≥35 kg/m²), moderate to severe malnutrition, frailty, sarcopenia, or projected duration of mechanical ventilation of more than four days beyond the point of screening. Feeding was started within 96 hours of ICU admission and continued for up to 28 days or death or transition to oral feeding. Despite appropriate separation in protein dosing, similar rates of survival to hospital discharge (46 versus 50 percent) and 60-day mortality (35 versus 32 percent) were reported. It should be noted that, common to similar studies, delivery to each group was significantly less than that prescribed (1.6 versus 0.9 g/kg per day, respectively). Subgroup analysis may have suggested a possible benefit favoring the usual dosing regimen in those with acute kidney failure and high illness severity scores. However, interpretation is limited due to the lack of blinding and poor recruitment, which underpowered the trial.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>One meta-analysis of four trials (637 patients and which did not include the trial above) that compared higher with lower prescriptions of protein reported similar ICU mortality (RD -0.01, 95% CI -0.06 to 0.04) and hospital mortality (RD -0.02, 95% CI -0.07 to 0.04) [<a href="#rid6">6</a>]. (See  <a class="medical medical_review" href="/z/d/html/821.html" rel="external">"Overview of nutrition support in burn patients"</a>.)</p><p></p><p class="headingAnchor" id="H3307645996"><span class="h2">Electrolytes, vitamins, minerals, trace elements</span><span class="headingEndMark"> — </span>Daily requirements of electrolytes, vitamins, minerals, trace elements are typically prescribed in the absence of known deficiency. Further details are provided separately. (See  <a class="medical medical_review" href="/z/d/html/1605.html" rel="external">"Nutrition support in intubated critically ill adult patients: Enteral nutrition", section on 'Other (vitamins, minerals, trace elements, fiber)'</a> and  <a class="medical medical_review" href="/z/d/html/1626.html" rel="external">"Nutrition support in intubated critically ill adult patients: Parenteral nutrition", section on 'Electrolytes'</a> and  <a class="medical medical_review" href="/z/d/html/1626.html" rel="external">"Nutrition support in intubated critically ill adult patients: Parenteral nutrition", section on 'Vitamins, minerals, and trace elements'</a>.)</p><p class="headingAnchor" id="H3168431274"><span class="h1">PATIENTS WITH MALNUTRITION</span><span class="headingEndMark"> — </span>The definition of malnutrition is described above. (See <a class="local">'Assess nutritional status'</a> above.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Timing and type of nutrition support</strong> – The ideal approach in patients with malnutrition is unknown. In this population, we adopt the same principles as in adequately nourished patients (ie, early enteral nutrition [EN] or <a class="drug drug_general" data-topicid="10307" href="/z/d/drug information/10307.html" rel="external">parenteral nutrition</a> [PN] at 36 to 48 hours). (See <a class="local">'Adequately nourished patients'</a> above.)</p><p></p><p class="bulletIndent1">We do not aggressively administer feeding within the first few hours of admission due to limited data that suggest potential harm in adequately nourished patients with this approach (eg, increased mortality) [<a href="#rid31">31,53</a>] and the potential risk of refeeding syndrome, which is high in this population. (See  <a class="medical medical_review" href="/z/d/html/15778.html" rel="external">"Anorexia nervosa in adults and adolescents: The refeeding syndrome"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Nutritional prescription</strong> – For patients who are underweight (body mass index &lt;18.5 kg/m<sup>2</sup>), we use the current weight as the initial dosing weight. Calculation of caloric intake based on ideal body weight could lead to the administration of excess initial calories and induce or worsen refeeding syndrome [<a href="#rid54">54</a>]. (See  <a class="medical medical_review" href="/z/d/html/15778.html" rel="external">"Anorexia nervosa in adults and adolescents: The refeeding syndrome"</a>.)</p><p></p><p class="bulletIndent1">We also suggest a similar prescription of calories and protein to that described in adequately nourished patients, although we sometimes increase the eventual target goal to 35 kilocalories (kcal)/kg of body weight per day but only in a relatively stable patient considered to be in a lower inflammatory state (ie, in early recovery phase of critical illness) (see <a class="local">'Calculating calorie and protein requirements in adequately nourished patients'</a> above). If goals cannot be met after 7 to 10 days of EN, we sometimes supplement EN with PN.</p><p></p><p class="bulletIndent1">We also administer <a class="drug drug_general" data-topicid="9988" href="/z/d/drug information/9988.html" rel="external">thiamine</a> supplementation in patients with malnutrition to prevent Wernicke encephalopathy. (See  <a class="medical medical_review" href="/z/d/html/4818.html" rel="external">"Wernicke encephalopathy"</a>.)</p><p></p><p class="bulletIndent1">Ideal prescriptions for patients who are chronically ill in the intensive care unit are unknown. In general, we choose a set target of 25 to 30 kcal/kg and/or perform calorimetry to facilitate goal setting.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Efficacy</strong> – Data to support this approach are limited since most clinical trials have excluded patients with malnutrition. Recommendations are generally based upon the biologic plausibility that excess caloric deficit is associated with increased morbidity in critically ill patients [<a href="#rid55">55</a>], indirect evidence of a potential benefit from early nutrition derived from the adequately nourished patient population (see <a class="local">'Adequately nourished patients'</a> above), and post-hoc data in patients at high nutritional risk that report similar outcomes when hypocaloric feeding is compared with normocaloric regimens [<a href="#rid44">44</a>].</p><p></p><p class="headingAnchor" id="H1124665719"><span class="h1">PATIENTS WITH OBESITY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Timing and type of nutrition</strong> – Most patients with obesity are adequately nourished while others may be inadequately nourished. For most patients with obesity (body mass index ≥30 kg/m<sup>2</sup>), the optimal approach to nutrition is unknown. As an initial strategy, we typically choose the same approach as that described for adequately nourished critically ill patients (ie, early enteral nutrition or <a class="drug drug_general" data-topicid="10307" href="/z/d/drug information/10307.html" rel="external">parenteral nutrition</a> at 36 to 48 hours). (See <a class="local">'Adequately nourished patients'</a> above.)</p><p></p><p class="bulletIndent1">However, for malnourished patients with obesity, we may use the principles of malnourishment to drive prescription (eg, calorie prescription may be slightly higher than for the adequately nourished patient). (See <a class="local">'Patients with malnutrition'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Nutritional prescription</strong> – For critically ill patients with obesity, there is little consensus among clinicians regarding the appropriate dosing weight.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In this population, we prefer to estimate nutritional needs based upon the individual's resting energy expenditure (REE) rather than their actual body weight (ABW) or ideal body weight (IBW). Although most experts agree that indirect calorimetry is the best method for REE measurement [<a href="#rid56">56</a>], we typically use predictive equations, such as the Penn State University 2010 predictive equation [<a href="#rid57">57-59</a>] since calorimeters are not widely available and calorie prescription based on calorimetry has not been adequately tested.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Alternatively, IBW-based adjustments can be performed. The purpose of adjusting the dosing weight of patients who are obese is to account for the absence of metabolic requirements by fat tissues:</p><p></p><div class="formulaContainer"><div class="formula"><p class="bulletIndent3"><span class="glyph">-</span>The most commonly employed method uses the IBW (<a class="calc calc_professional" href="/z/d/html/13489.html" rel="external">calculator 2</a>) and the ABW: Dosing weight = IBW + 0.4 (ABW – IBW)</p></div></div><div class="formulaContainer"><div class="formula"><p class="bulletIndent3"><span class="glyph">-</span>An alternative method is to use 110 percent of the IBW: Dosing weight = 1.1 × IBW</p></div></div><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Efficacy</strong> – Data regarding the impact of nutritional support on clinical outcomes in critically ill patients with obesity are limited to small observational series and inadequately powered randomized trials that have had mixed results [<a href="#rid6">6,60-67</a>]. Additionally, the presence of disease-related malnutrition in patients with obesity may confound the effect of obesity on measured outcomes [<a href="#rid66">66</a>]. Some trials suggest that hypocaloric, high-protein regimens are associated with a trend toward reduced length of stay in this population when compared with normocaloric strategies [<a href="#rid59">59-65</a>]. However, additional studies are warranted in this population before we would change our approach.</p><p></p><p>Additional guidelines for nutritional support of critically ill patients who have obesity can be found at the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Faspenjournals.onlinelibrary.wiley.com%2Fdoi%2Ffull%2F10.1177%2F0148607113499374&amp;token=7IY5IqdEFvYZ2gjAkv6gKckLPwQyC%2Fujw08pl39gvKVMMx7L5k3mylWsvLtp6%2FXlE8fUUyHnV9i8BYeHUfgmQ45C2bk8XK0u5vLbVJUHImo%3D&amp;TOPIC_ID=1617" target="_blank">American Society for Parenteral and Enteral Nutrition</a> [<a href="#rid59">59</a>].</p><p class="headingAnchor" id="H78798412"><span class="h1">CORONAVIRUS DISEASE 2019</span><span class="headingEndMark"> — </span>In patients with coronavirus disease 2019 (COVID-19) who develop critical illness, we use the same data that instruct nutrition support in all critically ill patients [<a href="#rid68">68</a>]. Select issues deserve attention (see  <a class="medical medical_review" href="/z/d/html/127419.html" rel="external">"COVID-19: Management of the intubated adult"</a>):</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Enteral nutrition while proning</strong> – Many patients with COVID-19 need prone positioning to successfully improve oxygenation. Several studies have demonstrated the safety of enteral tube feeding in the prone position, as well as the safety of continued feeding during changes in position [<a href="#rid69">69-72</a>]. Many experts temporarily stop tube feeding and empty the stomach before positioning to the supine or prone position and then promptly resume feeding. Our practice is to continue the feeding. Use of nasal bridles  (<a class="graphic graphic_figure graphicRef51735" href="/z/d/graphic/51735.html" rel="external">figure 1</a>) to secure nasal feeding tubes is reasonable, though infrequently used. (See  <a class="medical medical_review" href="/z/d/html/1630.html" rel="external">"Prone ventilation for adult patients with acute respiratory distress syndrome"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Malnutrition</strong> – Because in the initial phases of the pandemic the critical illness associated with acute COVID-19 was prolonged and the disease highly inflammatory, it is possible that malnutrition may have been more evident at a later point in the illness. However, whether a prolonged critical illness course still applies to COVID-19 due to evolving variants is unclear. (See <a class="local">'Patients with malnutrition'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Protein supplementation</strong> – The widespread use of the sedative <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">propofol</a>, which is administered in a lipid emulsion infusion (that provides calories but no protein), led to an increased effort to supplement protein over and above the routine amounts administered to critically ill non-COVID-19 patients. However, we believe that goals for protein intake should parallel that administered to non-COVID-19 patients. (See <a class="local">'Protein prescription'</a> above and  <a class="medical medical_review" href="/z/d/html/1605.html" rel="external">"Nutrition support in intubated critically ill adult patients: Enteral nutrition", section on 'Protein'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Nutrient supplementation</strong> – The use of nutrient supplementation has long been of interest for modulating disease outcomes in the critically ill. While there are weak data suggesting the possible benefit of high-dose <a class="drug drug_general" data-topicid="9776" href="/z/d/drug information/9776.html" rel="external">vitamin C</a> in COVID-19 [<a href="#rid73">73,74</a>], limited data in non-COVID-19 patients suggest no benefit [<a href="#rid75">75</a>]. We do not support routine use of any nutrient supplementation in any critically ill patient, unless they have a known deficiency prior to admission.</p><p></p><p class="bulletIndent1">Low vitamin D levels are associated with adverse outcomes in the critically ill, but these are likely disease epiphenomena as opposed to a true deficiency. Supplementation has failed to improve outcomes in several randomized control trials of critically ill patients without COVID-19 [<a href="#rid76">76,77</a>] and those with moderate to severe COVID-19 [<a href="#rid78">78-80</a>], except possibly those with severe vitamin D deficiency [<a href="#rid81">81,82</a>]. While trace element levels are decreased and associated with critical illness outcomes [<a href="#rid83">83</a>], there are no data to support a benefit in the critically ill COVID-19 patient or any other patient.</p><p></p><p class="bulletIndent1">Further data in non-COVID-19 patients are provided separately. (See  <a class="medical medical_review" href="/z/d/html/1605.html" rel="external">"Nutrition support in intubated critically ill adult patients: Enteral nutrition", section on 'Extra supplements of no proven benefit'</a>.)</p><p></p><p class="headingAnchor" id="H1197671541"><span class="h1">ADMINISTRATION AND MONITORING</span><span class="headingEndMark"> — </span>Administration of nutrition support requires that appropriate access is established and that the formulation, composition, delivery strategy, and delivery rate be determined. Once started, nutrition support must be monitored for tolerance and complications. These issues are different for enteral and <a class="drug drug_general" data-topicid="10307" href="/z/d/drug information/10307.html" rel="external">parenteral nutrition</a> and are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/1605.html" rel="external">"Nutrition support in intubated critically ill adult patients: Enteral nutrition"</a> and  <a class="medical medical_review" href="/z/d/html/1626.html" rel="external">"Nutrition support in intubated critically ill adult patients: Parenteral nutrition"</a>.)</p><p>We monitor all patients for "refeeding syndrome." Patients with malnutrition, patients with antecedent episodes of hypokalemia and hypophosphatemia, and those with conditions that predispose to electrolyte losses are likely to be at higher risk for refeeding syndrome. Further details on refeeding syndrome are provided separately. (See  <a class="medical medical_review" href="/z/d/html/15778.html" rel="external">"Anorexia nervosa in adults and adolescents: The refeeding syndrome"</a>.)</p><p class="headingAnchor" id="H2866782886"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/111340.html" rel="external">"Society guideline links: Nutrition support (parenteral and enteral nutrition) in adults"</a>.)</p><p class="headingAnchor" id="H546576905"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topics (see  <a class="medical medical_basics" href="/z/d/html/141278.html" rel="external">"Patient education: Malnutrition (The Basics)"</a> and  <a class="medical medical_basics" href="/z/d/html/141279.html" rel="external">"Patient education: Malnutrition – Discharge instructions (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H17"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Initial evaluation</strong> – Nutrition support refers to the enteral or parenteral provision of calories, protein, electrolytes, vitamins, minerals, and fluids. Once an intubated patient is admitted to the intensive care unit, we assess their nutritional status, the need for nutritional support, and the presence of any contraindications to select modes of delivery. (See <a class="local">'Introduction'</a> above and <a class="local">'Initial evaluation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Adequately nourished patients</strong> – Adequately nourished patients who are expected to be extubated within 24 to 36 hours of admission are likely able to eat after extubation and do not need nutrition support. For patients mechanically ventilated for longer than 36 hours, our approach is the following (see <a class="local">'Adequately nourished patients'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>No contraindications to enteral nutrition (EN)</strong> – For adequately nourished, intubated, critically ill patients without contraindications to enteral nutrition (EN), we suggest early (eg, 36 to 48 hours) rather than delayed EN (<a class="grade" href="https:///uptodate/show/grade_5" rel="external">Grade 2B</a>). Support for this approach is derived from limited data that suggest fewer episodes of infectious pneumonia and a possible mortality benefit when early EN is compared with delayed EN. (See <a class="local">'Patients without contraindications to enteral nutrition'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Contraindications to EN</strong> – For adequately nourished, critically ill patients with contraindications to EN  (<a class="graphic graphic_table graphicRef143318" href="/z/d/graphic/143318.html" rel="external">table 2</a>), we suggest early <a class="drug drug_general" data-topicid="10307" href="/z/d/drug information/10307.html" rel="external">parenteral nutrition</a> (PN; eg, 36 to 48 hours) rather than delaying nutrition support (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). While in the past our practice was to administer PN later in critical illness, data since then suggest that outcomes are similar when early PN is compared with late PN. Patients who are expected to need long term PN (ie, beyond critical illness) should also start their feeding early since it is assumed that the same benefit associated with short term feeding applies to those who require longer term feeding with PN.(See <a class="local">'Patients with contraindications to enteral feeding'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Prescription</strong> – For adequately nourished patients who have a normal body weight (body mass index [BMI] 18.5 to 24.9 kg/m<sup>2</sup>) or who are overweight (BMI 25 to 29.9 kg/m<sup>2</sup>), their current weight is used as the dosing weight. We suggest the following targets for the initial prescription(<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>) (see <a class="local">'Calculating calorie and protein requirements in adequately nourished patients'</a> above and <a class="local">'Electrolytes, vitamins, minerals, trace elements'</a> above):</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Total calories – 25 to 30 kilocalories (kcal)/kg administered at 12 kcal/kg of dosing weight per day and slowly increase to the target, typically 25 to 30 kcal/kg, over the next three to seven days, shorter if on PN (eg, two to three days)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Protein – 1.2 to 2.0 g/kg of protein per day (ie, high-protein diet)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Daily supplements – Recommended daily allowance of electrolytes, vitamins, minerals, and trace elements</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Patients with malnourishment</strong> – In this population, we adopt the same principles as in adequately nourished patients (ie, early EN or PN within 36 to 48 hours and current weight as the initial dosing weight). However, if the patient is stable and in recovery, an increase in the target goal to 35 kcal/kg of their body weight per day may be needed. Importantly, aggressively administering early feeding should be avoided due to the potential risk of refeeding syndrome. (See <a class="local">'Patients with malnutrition'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Patients with obesity</strong> – For patients with obesity (BMI ≥30 kg/m<sup>2</sup>), the timing and choice of nutrition should be the same as for the adequately nourished critically ill patient. (See <a class="local">'Patients with obesity'</a> above.)</p><p></p><p class="bulletIndent1">They key difference is that in patients with obesity, the nutritional needs are estimated based upon the individual's resting energy expenditure (REE; eg, indirect calorimetry) rather than their actual body weight (ABW) or ideal body weight (IBW), although the latter can be used if REE measurements are not available. Common IBW calculations include the following:</p><p></p><div class="formulaContainer"><div class="formula"><p class="bulletIndent3">Dosing weight = IBW + 0.4 (ABW – IBW)</p></div></div><p class="bulletIndent3"><strong>or</strong></p><div class="formulaContainer"><div class="formula"><p class="bulletIndent3">Dosing weight = 1.1 × IBW</p></div></div><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Administration</strong> – Administration of nutrition support requires that appropriate access is established and that the formulation, composition, delivery strategy, and delivery rate be determined. Once started, nutrition support must be monitored for tolerance and complications. These issues are different for EN and PN and are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/1605.html" rel="external">"Nutrition support in intubated critically ill adult patients: Enteral nutrition"</a> and  <a class="medical medical_review" href="/z/d/html/1626.html" rel="external">"Nutrition support in intubated critically ill adult patients: Parenteral nutrition"</a>.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Shaw JH, Koea JB. Metabolic basis for management of the septic surgical patient. World J Surg 1993; 17:154.</a></li><li class="breakAll">Babineau TJ, Borlase BC, Blackburn GL. Applied Total Parental Nutrition in the Critically Ill. In: Intensive Care Medicine, Rippe JM, Irwin RS, Alpert JS, Fink MP (Eds), Little, Brown and Co, Boston 1991. p.1675.</li><li><a class="nounderline abstract_t">Wanzer SH, Federman DD, Adelstein SJ, et al. The physician's responsibility toward hopelessly ill patients. A second look. N Engl J Med 1989; 320:844.</a></li><li><a class="nounderline abstract_t">Reintam Blaser A, Starkopf J, Alhazzani W, et al. Early enteral nutrition in critically ill patients: ESICM clinical practice guidelines. Intensive Care Med 2017; 43:380.</a></li><li><a class="nounderline abstract_t">McClave SA, Taylor BE, Martindale RG, et al. Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN J Parenter Enteral Nutr 2016; 40:159.</a></li><li><a class="nounderline abstract_t">Compher C, Bingham AL, McCall M, et al. Guidelines for the provision of nutrition support therapy in the adult critically ill patient: The American Society for Parenteral and Enteral Nutrition. JPEN J Parenter Enteral Nutr 2022; 46:12.</a></li><li><a class="nounderline abstract_t">Bechtold ML, Brown PM, Escuro A, et al. When is enteral nutrition indicated? JPEN J Parenter Enteral Nutr 2022; 46:1470.</a></li><li><a class="nounderline abstract_t">White JV, Guenter P, Jensen G, et al. Consensus statement: Academy of Nutrition and Dietetics and American Society for Parenteral and Enteral Nutrition: characteristics recommended for the identification and documentation of adult malnutrition (undernutrition). JPEN J Parenter Enteral Nutr 2012; 36:275.</a></li><li><a class="nounderline abstract_t">Mehta NM, Corkins MR, Lyman B, et al. Defining pediatric malnutrition: a paradigm shift toward etiology-related definitions. JPEN J Parenter Enteral Nutr 2013; 37:460.</a></li><li><a class="nounderline abstract_t">Milanez DSJ, Razzera EL, Lima J, Silva FM. Feasibility and criterion validity of the GLIM criteria in the critically ill: A prospective cohort study. JPEN J Parenter Enteral Nutr 2023; 47:754.</a></li><li><a class="nounderline abstract_t">Alves LF, de Jesus JDS, Britto VNM, et al. GLIM criteria to identify malnutrition in patients in hospital settings: A systematic review. JPEN J Parenter Enteral Nutr 2023; 47:702.</a></li><li><a class="nounderline abstract_t">Hiura G, Lebwohl B, Seres DS. Malnutrition Diagnosis in Critically Ill Patients Using 2012 Academy of Nutrition and Dietetics/American Society for Parenteral and Enteral Nutrition Standardized Diagnostic Characteristics Is Associated With Longer Hospital and Intensive Care Unit Length of Stay and Increased In-Hospital Mortality. JPEN J Parenter Enteral Nutr 2020; 44:256.</a></li><li><a class="nounderline abstract_t">Koretz RL. Death, morbidity and economics are the only end points for trials. Proc Nutr Soc 2005; 64:277.</a></li><li><a class="nounderline abstract_t">Merker M, Felder M, Gueissaz L, et al. Association of Baseline Inflammation With Effectiveness of Nutritional Support Among Patients With Disease-Related Malnutrition: A Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open 2020; 3:e200663.</a></li><li><a class="nounderline abstract_t">Stalder L, Kaegi-Braun N, Gressies C, et al. Prospective validation of five malnutrition screening and assessment instruments among medical inpatients: Secondary analysis of a randomized clinical trial. Clin Nutr 2022; 41:1307.</a></li><li><a class="nounderline abstract_t">Blackburn GL, Bistrian BR, Maini BS, et al. Nutritional and metabolic assessment of the hospitalized patient. JPEN J Parenter Enteral Nutr 1977; 1:11.</a></li><li><a class="nounderline abstract_t">Seres DS. Surrogate nutrition markers, malnutrition, and adequacy of nutrition support. Nutr Clin Pract 2005; 20:308.</a></li><li><a class="nounderline abstract_t">Bretschera C, Boesiger F, Kaegi-Braun N, et al. Admission serum albumin concentrations and response to nutritional therapy in hospitalised patients at malnutrition risk: Secondary analysis of a randomised clinical trial. EClinicalMedicine 2022; 45:101301.</a></li><li><a class="nounderline abstract_t">McClave SA, Martindale RG, Vanek VW, et al. Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN J Parenter Enteral Nutr 2009; 33:277.</a></li><li><a class="nounderline abstract_t">Reignier J, Boisramé-Helms J, Brisard L, et al. Enteral versus parenteral early nutrition in ventilated adults with shock: a randomised, controlled, multicentre, open-label, parallel-group study (NUTRIREA-2). Lancet 2018; 391:133.</a></li><li><a class="nounderline abstract_t">Khalid I, Doshi P, DiGiovine B. Early enteral nutrition and outcomes of critically ill patients treated with vasopressors and mechanical ventilation. Am J Crit Care 2010; 19:261.</a></li><li><a class="nounderline abstract_t">Marik PE, Zaloga GP. Early enteral nutrition in acutely ill patients: a systematic review. Crit Care Med 2001; 29:2264.</a></li><li><a class="nounderline abstract_t">Bufo AJ, Feldman S, Daniels GA, Lieberman RC. Early postoperative feeding. Dis Colon Rectum 1994; 37:1260.</a></li><li><a class="nounderline abstract_t">Reissman P, Teoh TA, Cohen SM, et al. Is early oral feeding safe after elective colorectal surgery? A prospective randomized trial. Ann Surg 1995; 222:73.</a></li><li><a class="nounderline abstract_t">Kaur N, Gupta MK, Minocha VR. Early enteral feeding by nasoenteric tubes in patients with perforation peritonitis. World J Surg 2005; 29:1023.</a></li><li><a class="nounderline abstract_t">Andersen HK, Lewis SJ, Thomas S. Early enteral nutrition within 24h of colorectal surgery versus later commencement of feeding for postoperative complications. Cochrane Database Syst Rev 2006; :CD004080.</a></li><li><a class="nounderline abstract_t">Mentec H, Dupont H, Bocchetti M, et al. Upper digestive intolerance during enteral nutrition in critically ill patients: frequency, risk factors, and complications. Crit Care Med 2001; 29:1955.</a></li><li><a class="nounderline abstract_t">Ceydeli A. Early postoperative enteral feeding increases anastomotic strength in a peritonitis model. Am J Surg 2003; 185:605.</a></li><li><a class="nounderline abstract_t">Harvey SE, Parrott F, Harrison DA, et al. Trial of the route of early nutritional support in critically ill adults. N Engl J Med 2014; 371:1673.</a></li><li><a class="nounderline abstract_t">Tian F, Heighes PT, Allingstrup MJ, Doig GS. Early Enteral Nutrition Provided Within 24 Hours of ICU Admission: A Meta-Analysis of Randomized Controlled Trials. Crit Care Med 2018; 46:1049.</a></li><li><a class="nounderline abstract_t">Braunschweig CA, Sheean PM, Peterson SJ, et al. Intensive nutrition in acute lung injury: a clinical trial (INTACT). JPEN J Parenter Enteral Nutr 2015; 39:13.</a></li><li><a class="nounderline abstract_t">Reignier J, Plantefeve G, Mira JP, et al. Low versus standard calorie and protein feeding in ventilated adults with shock: a randomised, controlled, multicentre, open-label, parallel-group trial (NUTRIREA-3). Lancet Respir Med 2023; 11:602.</a></li><li><a class="nounderline abstract_t">Casaer MP, Mesotten D, Hermans G, et al. Early versus late parenteral nutrition in critically ill adults. N Engl J Med 2011; 365:506.</a></li><li><a class="nounderline abstract_t">Heidegger CP, Berger MM, Graf S, et al. Optimisation of energy provision with supplemental parenteral nutrition in critically ill patients: a randomised controlled clinical trial. Lancet 2013; 381:385.</a></li><li><a class="nounderline abstract_t">Kutsogiannis J, Alberda C, Gramlich L, et al. Early use of supplemental parenteral nutrition in critically ill patients: results of an international multicenter observational study. Crit Care Med 2011; 39:2691.</a></li><li><a class="nounderline abstract_t">Doig GS, Simpson F, Sweetman EA, et al. Early parenteral nutrition in critically ill patients with short-term relative contraindications to early enteral nutrition: a randomized controlled trial. JAMA 2013; 309:2130.</a></li><li><a class="nounderline abstract_t">Ibrahim EH, Mehringer L, Prentice D, et al. Early versus late enteral feeding of mechanically ventilated patients: results of a clinical trial. JPEN J Parenter Enteral Nutr 2002; 26:174.</a></li><li><a class="nounderline abstract_t">Rice TW, Mogan S, Hays MA, et al. Randomized trial of initial trophic versus full-energy enteral nutrition in mechanically ventilated patients with acute respiratory failure. Crit Care Med 2011; 39:967.</a></li><li><a class="nounderline abstract_t">Charles EJ, Petroze RT, Metzger R, et al. Hypocaloric compared with eucaloric nutritional support and its effect on infection rates in a surgical intensive care unit: a randomized controlled trial. Am J Clin Nutr 2014; 100:1337.</a></li><li><a class="nounderline abstract_t">National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network, Rice TW, Wheeler AP, et al. Initial trophic vs full enteral feeding in patients with acute lung injury: the EDEN randomized trial. JAMA 2012; 307:795.</a></li><li><a class="nounderline abstract_t">Choi EY, Park DA, Park J. Calorie intake of enteral nutrition and clinical outcomes in acutely critically ill patients: a meta-analysis of randomized controlled trials. JPEN J Parenter Enteral Nutr 2015; 39:291.</a></li><li><a class="nounderline abstract_t">Arabi YM, Aldawood AS, Haddad SH, et al. Permissive Underfeeding or Standard Enteral Feeding in Critically Ill Adults. N Engl J Med 2015; 372:2398.</a></li><li><a class="nounderline abstract_t">Perman MI, Ciapponi A, Franco JV, et al. Prescribed hypocaloric nutrition support for critically-ill adults. Cochrane Database Syst Rev 2018; 6:CD007867.</a></li><li><a class="nounderline abstract_t">Arabi YM, Aldawood AS, Al-Dorzi HM, et al. Permissive Underfeeding or Standard Enteral Feeding in High- and Low-Nutritional-Risk Critically Ill Adults. Post Hoc Analysis of the PermiT Trial. Am J Respir Crit Care Med 2017; 195:652.</a></li><li><a class="nounderline abstract_t">Scheinkestel CD, Kar L, Marshall K, et al. Prospective randomized trial to assess caloric and protein needs of critically Ill, anuric, ventilated patients requiring continuous renal replacement therapy. Nutrition 2003; 19:909.</a></li><li><a class="nounderline abstract_t">Ferrie S, Allman-Farinelli M, Daley M, Smith K. Protein Requirements in the Critically Ill: A Randomized Controlled Trial Using Parenteral Nutrition. JPEN J Parenter Enteral Nutr 2016; 40:795.</a></li><li><a class="nounderline abstract_t">Doig GS, Simpson F, Bellomo R, et al. Intravenous amino acid therapy for kidney function in critically ill patients: a randomized controlled trial. Intensive Care Med 2015; 41:1197.</a></li><li><a class="nounderline abstract_t">van Zanten ARH, Petit L, De Waele J, et al. Very high intact-protein formula successfully provides protein intake according to nutritional recommendations in overweight critically ill patients: a double-blind randomized trial. Crit Care 2018; 22:156.</a></li><li><a class="nounderline abstract_t">Fetterplace K, Deane AM, Tierney A, et al. Targeted Full Energy and Protein Delivery in Critically Ill Patients: A Pilot Randomized Controlled Trial (FEED Trial). JPEN J Parenter Enteral Nutr 2018; 42:1252.</a></li><li><a class="nounderline abstract_t">Weijs PJ, Stapel SN, de Groot SD, et al. Optimal protein and energy nutrition decreases mortality in mechanically ventilated, critically ill patients: a prospective observational cohort study. JPEN J Parenter Enteral Nutr 2012; 36:60.</a></li><li><a class="nounderline abstract_t">Plank LD, Connolly AB, Hill GL. Sequential changes in the metabolic response in severely septic patients during the first 23 days after the onset of peritonitis. Ann Surg 1998; 228:146.</a></li><li><a class="nounderline abstract_t">Heyland DK, Patel J, Compher C, et al. The effect of higher protein dosing in critically ill patients with high nutritional risk (EFFORT Protein): an international, multicentre, pragmatic, registry-based randomised trial. Lancet 2023; 401:568.</a></li><li><a class="nounderline abstract_t">Feinberg J, Nielsen EE, Korang SK, et al. Nutrition support in hospitalised adults at nutritional risk. Cochrane Database Syst Rev 2017; 5:CD011598.</a></li><li><a class="nounderline abstract_t">Kraft MD, Btaiche IF, Sacks GS. Review of the refeeding syndrome. Nutr Clin Pract 2005; 20:625.</a></li><li><a class="nounderline abstract_t">Dvir D, Cohen J, Singer P. Computerized energy balance and complications in critically ill patients: an observational study. Clin Nutr 2006; 25:37.</a></li><li><a class="nounderline abstract_t">Gonzalez-Granda A, Schollenberger A, Haap M, et al. Optimization of Nutrition Therapy with the Use of Calorimetry to Determine and Control Energy Needs in Mechanically Ventilated Critically Ill Patients: The ONCA Study, a Randomized, Prospective Pilot Study. JPEN J Parenter Enteral Nutr 2019; 43:481.</a></li><li><a class="nounderline abstract_t">Frankenfield DC, Coleman A, Alam S, Cooney RN. Analysis of estimation methods for resting metabolic rate in critically ill adults. JPEN J Parenter Enteral Nutr 2009; 33:27.</a></li><li><a class="nounderline abstract_t">Frankenfield DC, Ashcraft CM, Galvan DA. Prediction of resting metabolic rate in critically ill patients at the extremes of body mass index. JPEN J Parenter Enteral Nutr 2013; 37:361.</a></li><li><a class="nounderline abstract_t">Choban P, Dickerson R, Malone A, et al. A.S.P.E.N. Clinical guidelines: nutrition support of hospitalized adult patients with obesity. JPEN J Parenter Enteral Nutr 2013; 37:714.</a></li><li><a class="nounderline abstract_t">Choban PS, Burge JC, Scales D, Flancbaum L. Hypoenergetic nutrition support in hospitalized obese patients: a simplified method for clinical application. Am J Clin Nutr 1997; 66:546.</a></li><li><a class="nounderline abstract_t">Burge JC, Goon A, Choban PS, Flancbaum L. Efficacy of hypocaloric total parenteral nutrition in hospitalized obese patients: a prospective, double-blind randomized trial. JPEN J Parenter Enteral Nutr 1994; 18:203.</a></li><li><a class="nounderline abstract_t">Dickerson RN, Boschert KJ, Kudsk KA, Brown RO. Hypocaloric enteral tube feeding in critically ill obese patients. Nutrition 2002; 18:241.</a></li><li><a class="nounderline abstract_t">Dickerson RN, Medling TL, Smith AC, et al. Hypocaloric, high-protein nutrition therapy in older vs younger critically ill patients with obesity. JPEN J Parenter Enteral Nutr 2013; 37:342.</a></li><li><a class="nounderline abstract_t">Hamilton C, Dasari V, Shatnawei A, et al. Hypocaloric home parenteral nutrition and nutrition parameters in patients following bariatric surgery. Nutr Clin Pract 2011; 26:577.</a></li><li><a class="nounderline abstract_t">Dickerson RN, Rosato EF, Mullen JL. Net protein anabolism with hypocaloric parenteral nutrition in obese stressed patients. Am J Clin Nutr 1986; 44:747.</a></li><li><a class="nounderline abstract_t">Robinson MK, Mogensen KM, Casey JD, et al. The relationship among obesity, nutritional status, and mortality in the critically ill. Crit Care Med 2015; 43:87.</a></li><li><a class="nounderline abstract_t">Mogensen KM, Andrew BY, Corona JC, Robinson MK. Validation of the Society of Critical Care Medicine and American Society for Parenteral and Enteral Nutrition Recommendations for Caloric Provision to Critically Ill Obese Patients: A Pilot Study. JPEN J Parenter Enteral Nutr 2016; 40:713.</a></li><li><a class="nounderline abstract_t">Martindale R, Patel JJ, Taylor B, et al. Nutrition Therapy in Critically Ill Patients With Coronavirus Disease 2019. JPEN J Parenter Enteral Nutr 2020; 44:1174.</a></li><li><a class="nounderline abstract_t">van der Voort PH, Zandstra DF. Enteral feeding in the critically ill: comparison between the supine and prone positions: a prospective crossover study in mechanically ventilated patients. Crit Care 2001; 5:216.</a></li><li><a class="nounderline abstract_t">Saez de la Fuente I, Saez de la Fuente J, Quintana Estelles MD, et al. Enteral Nutrition in Patients Receiving Mechanical Ventilation in a Prone Position. JPEN J Parenter Enteral Nutr 2016; 40:250.</a></li><li><a class="nounderline abstract_t">Reignier J, Thenoz-Jost N, Fiancette M, et al. Early enteral nutrition in mechanically ventilated patients in the prone position. Crit Care Med 2004; 32:94.</a></li><li><a class="nounderline abstract_t">Reignier J, Dimet J, Martin-Lefevre L, et al. Before-after study of a standardized ICU protocol for early enteral feeding in patients turned in the prone position. Clin Nutr 2010; 29:210.</a></li><li><a class="nounderline abstract_t">Langlois PL, Manzanares W, Adhikari NKJ, et al. Vitamin C Administration to the Critically Ill: A Systematic Review and Meta-Analysis. JPEN J Parenter Enteral Nutr 2019; 43:335.</a></li><li><a class="nounderline abstract_t">Zhang M, Jativa DF. Vitamin C supplementation in the critically ill: A systematic review and meta-analysis. SAGE Open Med 2018; 6:2050312118807615.</a></li><li><a class="nounderline abstract_t">Rawat D, Roy A, Maitra S, et al. Vitamin C and COVID-19 treatment: A systematic review and meta-analysis of randomized controlled trials. Diabetes Metab Syndr 2021; 15:102324.</a></li><li><a class="nounderline abstract_t">National Heart, Lung, and Blood Institute PETAL Clinical Trials Network, Ginde AA, Brower RG, et al. Early High-Dose Vitamin D3 for Critically Ill, Vitamin D-Deficient Patients. N Engl J Med 2019; 381:2529.</a></li><li><a class="nounderline abstract_t">Nair P, Venkatesh B, Lee P, et al. A Randomized Study of a Single Dose of Intramuscular Cholecalciferol in Critically Ill Adults. Crit Care Med 2015; 43:2313.</a></li><li><a class="nounderline abstract_t">Domazet Bugarin J, Dosenovic S, Ilic D, et al. Vitamin D Supplementation and Clinical Outcomes in Severe COVID-19 Patients-Randomized Controlled Trial. Nutrients 2023; 15.</a></li><li><a class="nounderline abstract_t">Bychinin MV, Klypa TV, Mandel IA, et al. Effect of vitamin D3 supplementation on cellular immunity and inflammatory markers in COVID-19 patients admitted to the ICU. Sci Rep 2022; 12:18604.</a></li><li><a class="nounderline abstract_t">Cannata-Andía JB, Díaz-Sottolano A, Fernández P, et al. A single-oral bolus of 100,000 IU of cholecalciferol at hospital admission did not improve outcomes in the COVID-19 disease: the COVID-VIT-D-a randomised multicentre international clinical trial. BMC Med 2022; 20:83.</a></li><li><a class="nounderline abstract_t">De Niet S, Trémège M, Coffiner M, et al. Positive Effects of Vitamin D Supplementation in Patients Hospitalized for COVID-19: A Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients 2022; 14.</a></li><li><a class="nounderline abstract_t">Murai IH, Fernandes AL, Antonangelo L, et al. Effect of a Single High-Dose Vitamin D3 on the Length of Hospital Stay of Severely 25-Hydroxyvitamin D-Deficient Patients with COVID-19. Clinics (Sao Paulo) 2021; 76:e3549.</a></li><li><a class="nounderline abstract_t">Lee YH, Bang ES, Lee JH, et al. Serum Concentrations of Trace Elements Zinc, Copper, Selenium, and Manganese in Critically Ill Patients. Biol Trace Elem Res 2019; 188:316.</a></li></ol></div><div id="topicVersionRevision">Topic 1617 Version 59.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8511908" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Metabolic basis for management of the septic surgical patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8511908" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Metabolic basis for management of the septic surgical patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2604764" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : The physician's responsibility toward hopelessly ill patients. A second look.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28168570" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Early enteral nutrition in critically ill patients: ESICM clinical practice guidelines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26773077" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34784064" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Guidelines for the provision of nutrition support therapy in the adult critically ill patient: The American Society for Parenteral and Enteral Nutrition.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35838308" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : When is enteral nutrition indicated?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22535923" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Consensus statement: Academy of Nutrition and Dietetics and American Society for Parenteral and Enteral Nutrition: characteristics recommended for the identification and documentation of adult malnutrition (undernutrition).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23528324" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Defining pediatric malnutrition: a paradigm shift toward etiology-related definitions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37329138" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Feasibility and criterion validity of the GLIM criteria in the critically ill: A prospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37314206" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : GLIM criteria to identify malnutrition in patients in hospital settings: A systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31032991" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Malnutrition Diagnosis in Critically Ill Patients Using 2012 Academy of Nutrition and Dietetics/American Society for Parenteral and Enteral Nutrition Standardized Diagnostic Characteristics Is Associated With Longer Hospital and Intensive Care Unit Length of Stay and Increased In-Hospital Mortality.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16048658" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Death, morbidity and economics are the only end points for trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32154887" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Association of Baseline Inflammation With Effectiveness of Nutritional Support Among Patients With Disease-Related Malnutrition: A Secondary Analysis of a Randomized Clinical Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35552050" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Prospective validation of five malnutrition screening and assessment instruments among medical inpatients: Secondary analysis of a randomized clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/98649" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Nutritional and metabolic assessment of the hospitalized patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16207668" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Surrogate nutrition markers, malnutrition, and adequacy of nutrition support.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35198927" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Admission serum albumin concentrations and response to nutritional therapy in hospitalised patients at malnutrition risk: Secondary analysis of a randomised clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19398613" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29128300" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Enteral versus parenteral early nutrition in ventilated adults with shock: a randomised, controlled, multicentre, open-label, parallel-group study (NUTRIREA-2).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20436064" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Early enteral nutrition and outcomes of critically ill patients treated with vasopressors and mechanical ventilation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11801821" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Early enteral nutrition in acutely ill patients: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7995155" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Early postoperative feeding.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7618972" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Is early oral feeding safe after elective colorectal surgery? A prospective randomized trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15981045" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Early enteral feeding by nasoenteric tubes in patients with perforation peritonitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17054196" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Early enteral nutrition within 24h of colorectal surgery versus later commencement of feeding for postoperative complications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11588461" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Upper digestive intolerance during enteral nutrition in critically ill patients: frequency, risk factors, and complications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12781899" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Early postoperative enteral feeding increases anastomotic strength in a peritonitis model.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25271389" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Trial of the route of early nutritional support in critically ill adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29629984" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Early Enteral Nutrition Provided Within 24 Hours of ICU Admission: A Meta-Analysis of Randomized Controlled Trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24722769" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Intensive nutrition in acute lung injury: a clinical trial (INTACT).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36958363" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Low versus standard calorie and protein feeding in ventilated adults with shock: a randomised, controlled, multicentre, open-label, parallel-group trial (NUTRIREA-3).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21714640" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Early versus late parenteral nutrition in critically ill adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23218813" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Optimisation of energy provision with supplemental parenteral nutrition in critically ill patients: a randomised controlled clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21765355" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Early use of supplemental parenteral nutrition in critically ill patients: results of an international multicenter observational study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23689848" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Early parenteral nutrition in critically ill patients with short-term relative contraindications to early enteral nutrition: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12005458" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Early versus late enteral feeding of mechanically ventilated patients: results of a clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21242788" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Randomized trial of initial trophic versus full-energy enteral nutrition in mechanically ventilated patients with acute respiratory failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25332331" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Hypocaloric compared with eucaloric nutritional support and its effect on infection rates in a surgical intensive care unit: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22307571" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Initial trophic vs full enteral feeding in patients with acute lung injury: the EDEN randomized trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25078609" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Calorie intake of enteral nutrition and clinical outcomes in acutely critically ill patients: a meta-analysis of randomized controlled trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25992505" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Permissive Underfeeding or Standard Enteral Feeding in Critically Ill Adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29864793" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Prescribed hypocaloric nutrition support for critically-ill adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27589411" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Permissive Underfeeding or Standard Enteral Feeding in High- and Low-Nutritional-Risk Critically Ill Adults. Post Hoc Analysis of the PermiT Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14624937" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Prospective randomized trial to assess caloric and protein needs of critically Ill, anuric, ventilated patients requiring continuous renal replacement therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26635305" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Protein Requirements in the Critically Ill: A Randomized Controlled Trial Using Parenteral Nutrition.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25925203" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Intravenous amino acid therapy for kidney function in critically ill patients: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29895309" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Very high intact-protein formula successfully provides protein intake according to nutritional recommendations in overweight critically ill patients: a double-blind randomized trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29701878" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Targeted Full Energy and Protein Delivery in Critically Ill Patients: A Pilot Randomized Controlled Trial (FEED Trial).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22167076" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Optimal protein and energy nutrition decreases mortality in mechanically ventilated, critically ill patients: a prospective observational cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9712558" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Sequential changes in the metabolic response in severely septic patients during the first 23 days after the onset of peritonitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36708732" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : The effect of higher protein dosing in critically ill patients with high nutritional risk (EFFORT Protein): an international, multicentre, pragmatic, registry-based randomised trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28524930" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Nutrition support in hospitalised adults at nutritional risk.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16306300" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Review of the refeeding syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16321459" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Computerized energy balance and complications in critically ill patients: an observational study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30251255" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Optimization of Nutrition Therapy with the Use of Calorimetry to Determine and Control Energy Needs in Mechanically Ventilated Critically Ill Patients: The ONCA Study, a Randomized, Prospective Pilot Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19011147" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Analysis of estimation methods for resting metabolic rate in critically ill adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22898794" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Prediction of resting metabolic rate in critically ill patients at the extremes of body mass index.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23976769" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : A.S.P.E.N. Clinical guidelines: nutrition support of hospitalized adult patients with obesity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9280171" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Hypoenergetic nutrition support in hospitalized obese patients: a simplified method for clinical application.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8064994" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Efficacy of hypocaloric total parenteral nutrition in hospitalized obese patients: a prospective, double-blind randomized trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11882397" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Hypocaloric enteral tube feeding in critically ill obese patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23169899" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Hypocaloric, high-protein nutrition therapy in older vs younger critically ill patients with obesity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21947640" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Hypocaloric home parenteral nutrition and nutrition parameters in patients following bariatric surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3098083" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Net protein anabolism with hypocaloric parenteral nutrition in obese stressed patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25289931" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : The relationship among obesity, nutritional status, and mortality in the critically ill.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25897016" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Validation of the Society of Critical Care Medicine and American Society for Parenteral and Enteral Nutrition Recommendations for Caloric Provision to Critically Ill Obese Patients: A Pilot Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32462719" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Nutrition Therapy in Critically Ill Patients With Coronavirus Disease 2019.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11511335" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Enteral feeding in the critically ill: comparison between the supine and prone positions: a prospective crossover study in mechanically ventilated patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25274497" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Enteral Nutrition in Patients Receiving Mechanical Ventilation in a Prone Position.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14707565" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Early enteral nutrition in mechanically ventilated patients in the prone position.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19709786" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Before-after study of a standardized ICU protocol for early enteral feeding in patients turned in the prone position.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30452091" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Vitamin C Administration to the Critically Ill: A Systematic Review and Meta-Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30364374" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Vitamin C supplementation in the critically ill: A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34739908" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Vitamin C and COVID-19 treatment: A systematic review and meta-analysis of randomized controlled trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31826336" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Early High-Dose Vitamin D3 for Critically Ill, Vitamin D-Deficient Patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26186566" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : A Randomized Study of a Single Dose of Intramuscular Cholecalciferol in Critically Ill Adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36904232" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Vitamin D Supplementation and Clinical Outcomes in Severe COVID-19 Patients-Randomized Controlled Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36329227" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Effect of vitamin D3 supplementation on cellular immunity and inflammatory markers in COVID-19 patients admitted to the ICU.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35177066" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : A single-oral bolus of 100,000 IU of cholecalciferol at hospital admission did not improve outcomes in the COVID-19 disease: the COVID-VIT-D-a randomised multicentre international clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35893907" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Positive Effects of Vitamin D Supplementation in Patients Hospitalized for COVID-19: A Randomized, Double-Blind, Placebo-Controlled Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34852148" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Effect of a Single High-Dose Vitamin D3 on the Length of Hospital Stay of Severely 25-Hydroxyvitamin D-Deficient Patients with COVID-19.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30047077" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Serum Concentrations of Trace Elements Zinc, Copper, Selenium, and Manganese in Critically Ill Patients.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
